Education
About Us
Working with TipRanks
Follow Us
Diagnos (TSE:ADK)
:ADK
Total Valuation
Diagnos has a market cap or net worth of C$33.61M. The enterprise value is C$20.19M.
Market CapC$33.61M
Enterprise ValueC$20.19M
Share Statistics
Diagnos has 101,862,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding101,862,976
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Diagnos’s return on equity (ROE) is 1.02 and return on invested capital (ROIC) is -2007.95%.
Return on Equity (ROE)1.02
Return on Assets (ROA)-4.70
Return on Invested Capital (ROIC)-2007.95%
Return on Capital Employed (ROCE)2.80
Revenue Per Employee6.49K
Profits Per Employee-267.90K
Employee Count16
Asset Turnover0.26
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Diagnos is ―. Diagnos’s PEG ratio is -0.45.
PE Ratio―
PS Ratio117.69
PB Ratio-6.56
Price to Fair Value-6.56
Price to FCF-9.28
Price to Operating Cash Flow-8.63
PEG Ratio-0.45
Income Statement
In the last 12 months, Diagnos had revenue of 103.80K and earned -4.29M in profits. Earnings per share was -0.05.
Revenue103.80K
Gross Profit-943.56K
Operating Income-3.81M
Pretax Income-4.29M
Net Income-4.29M
EBITDA-3.56M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -4.06M and capital expenditures -14.30K, giving a free cash flow of -4.08M billion.
Operating Cash Flow-4.06M
Free Cash Flow-4.08M
Free Cash Flow per Share-0.04
Dividends & Yields
Diagnos pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.30
52-Week Price Change-5.88%
50-Day Moving Average0.33
200-Day Moving Average0.27
Relative Strength Index (RSI)49.57
Average Volume (3m)342.67K
Important Dates
Diagnos upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateNov 20, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Diagnos as a current ratio of 0.25, with Debt / Equity ratio of -311.44%
Current Ratio0.25
Quick Ratio0.25
Debt to Market Cap0.15
Net Debt to EBITDA-1.21
Interest Coverage Ratio-4.88
Taxes
In the past 12 months, Diagnos has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Diagnos EV to EBITDA ratio is -9.40, with an EV/FCF ratio of -10.65.
EV to Sales135.12
EV to EBITDA-9.40
EV to Free Cash Flow-10.65
EV to Operating Cash Flow-10.71
Balance Sheet
Diagnos has C$737.25K in cash and marketable securities with C$2.39M in debt, giving a net cash position of -C$1.65M billion.
Cash & Marketable SecuritiesC$737.25K
Total DebtC$2.39M
Net Cash-C$1.65M
Net Cash Per Share-C$0.02
Tangible Book Value Per Share-C$0.04
Margins
Gross margin is -1418.21%, with operating margin of -1578.00%, and net profit margin of -1833.93%.
Gross Margin-1418.21%
Operating Margin-1578.00%
Pretax Margin-1833.93%
Net Profit Margin-1833.93%
EBITDA Margin-1437.61%
EBIT Margin-1510.60%
Analyst Forecast
The average price target for Diagnos is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-48.53%
EPS Growth Forecast-9.66%